Showing results (211-220 of 335) with videos related to
Sort By:
Pageof 34
Oxidative Medicine and Cellular Longevity|June 5, 2014
Nrf2 deficiency exaggerates doxorubicin-induced cardiotoxicity and cardiac dysfunctionSiying Li, Wenjuan Wang, Ting Niu, et al.Frontiers in Oncology|March 27, 2023
A novel conditioning regimen of chidamide, cladribine, gemcitabine, and busulfan in the autologous stem cell transplantation of aggressive T-cell lymphomaQiang Zeng, Hang Zhang, Pu Kuang, et al.Journal of Cancer|April 15, 2021
Real-world data combined with studies on Regulatory B Cells for newly diagnosed Multiple Myeloma from a tertiary referral Hospital in South-Western ChinaZhongqing Zou, Tingting Guo, Jian Cui, et al.International Journal of Pharmaceutics|December 18, 2018
Methotrexate-loaded biodegradable polymeric micelles for lymphoma therapyMeng Yao Wang, Ying Qu, Dan Rong Hu, et al.International Immunopharmacology|July 11, 2016
Protective effect of gentiopicroside against dextran sodium sulfate induced colitis in miceYa-Ting Niu, Yu-Ping Zhao, Yan-Fang Jiao, et al.Blood|January 9, 2020
Nivolumab treatment of relapsed/refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in adultsPengpeng Liu, Xiangyu Pan, Chong Chen, et al.American Journal of Translational Research|September 15, 2022
A novel immune prognostic model of non-M3 acute myeloid leukemiaHong Ding, Yu Feng, Juan Xu, et al.Nucleic Acids Research|November 12, 2023
StemDriver: a knowledgebase of gene functions for hematopoietic stem cell fate determinationYangyang Luo, Jingjing Guo, Jianguo Wen, et al.Cancer Medicine|July 20, 2024
Phase I study of TQB3602, an oral proteasome inhibitor, in relapsed and refractory multiple myelomaWenjiao Tang, Yan Li, Li Zhang, et al.Annals of Hematology|October 21, 2020
Low-dose ruxolitinib shows effective in treating myelofibrosisYunfan Yang, Hongmei Luo, Yuhuan Zheng, et al.Pageof 34